Durham, N.C. – January 24, 2018 – Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the first patient has been enrolled in the post approval study to evaluate the Tryton Side Branch Stent System™ for the treatment of coronary artery disease. The first case was performed by R. Lee Jobe, M.D., …
Tryton Medical announces new CEO and president
Durham, N.C. – Jan. 3, 2018 – Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the company has appointed Carl J. St. Bernard as president and chief executive officer. St. Bernard has a long track record growing new and established businesses in pharmaceuticals, consumer health products, medical devices and diagnostic markets. …
Innovative Tryton Side Branch Stent Recognized with the Premier Technology Breakthrough Award
DUBLIN, Ohio, September 19, 2017 — Cardinal Health and Tryton Medical Inc. today announced that the Tryton coronary Side Branch Stent was recognized by Premier Inc., a leading healthcare improvement company, with the prestigious Technology Breakthrough Award. Premier’s Technology Breakthrough Award is granted to cutting-edge products that significantly advance healthcare in terms of safety, clinical outcomes and/or operational efficiency. The …
Global Bifurcation Leader Tryton Medical Announces Events at TCT 2014
Press release TCT 2014 announcement – Sep 12
Tryton Medical Enrolls First U.S. Patient in the EXTENDED ACCESS Registry
Tryton Medical Enrolls First U.S. Patient in the EXTENDED ACCESS Registry
Tryton Medical Completes $20 Million Equity Financing
Tryton Medical Financing September 2014 Press Release
EuroPCR 2014 Events Announcement
EuroPCR 2014 Events Announcement
Tryton Medical Receives CE-mark for the Left Main Indication
Tryton Medical Receives CE-mark for LM Indication 2 13 14[2]
Tryton Medical Establishes Bifurcation Institute
Tryton Medical Establishes Bifurcation Institute
Tryton IDE Press Release
Tryton IDE Press Release